Seven benzodiazepines are now available for clinical use in Britain: chlordiazepoxide (Librium - Roche; Tropium - DDSA), diazepam (Valium - Roche; Atensine - Berk), nitrazepam (Mogadon - Roche), oxazepam (Serenid-D - Wyeth), medazepam (Nobrium - Roche), lorazepam (Ativan - Wyeth) and, the latest arrival, clorazepate (Tranxene - Boehringer Ingelheim). More are being developed. Nitrazepam is usually prescribed as a hypnotic, the remainder primarily for the relief of anxiety. Although the introduction of each new compound has been accompanied by claims that it represents a significant advance in therapy, the evidence supporting these claims is tenuous.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.